About Us Advertise Careers Contact Us Privacy Policy Community Guidelines
Locating… 13°C English WhatsApp Alerts Email Alerts
BREAKING NEWS
EHang completes Sri Lanka’s first human-carrying eVTOL flights - Asian Aviation What’s Happening in Space Policy November 15-21, 2026 Vulcan’s Return-to-Flight Fails How Some News Gets Wings: An Alternative Reading On Viral Footage Of Israeli Tourists In Sri Lanka - OpEd - Eurasia Review Starship Returns to its Launch Pad From Orbit After tracking more than 440 female Asian elephants in Sri Lanka for 12 years, US researchers found that - The Times of India ULA suffers first total mission failure with loss of Vulcan rocket carrying 40 Amazon Leo satellites Sri Lanka records large-scale seasonal butterfly movement — Mongabay - UA.NEWS As butterflies sweep Sri Lanka, global study finds expanding ranges linked to climate change - news - Mongabay APOD: 2026 November 16 – NGC 7129: Star Formation with Jets from Webb
SRI LANKA NEWS

San Diego company says its supplement helps keep you from developing diabetes. Scientists are skeptical - San Diego Union-Tribune

Lanka Hit News • Aug 19, 2020 · 6y ago • 4 min read
Share:

Local experts are questioning a study reporting that a San Diego company’s nutritional supplement helps prevent those teetering on the edge of type 2 diabetes from developing the disease.

“It’s published. It’s proven. When I talk to folks, they always say, ‘Well, we know about supplements, they’re all just a load of hooey,’’’ said John Burd, CEO of Lysulin. “Lysulin is the exact opposite.”

According to the company’s website , “Lysulin is the only supplement clinically shown to help maintain healthy blood sugar and A1c levels for people with diabetes or prediabetes.”

But Dr. Candis Morello, who runs a diabetes clinic at the Veteran Affairs San Diego Healthcare System, isn’t so sure.

“I’m always looking at, ‘Does it truly have enough evidence-based medicine to justify the cost?’” Morello said. “I don’t see that in this case.”

Lysulin sells a one-month supply of its eponymous supplement for $29.95. The company announced this week that the supplement can now be bought through Walmart.com.

Burd founded Lysulin in 2017, but he is best known as a former CEO and founder of Dexcom, a San Diego company that is a leader in marketing devices that continuously monitor blood sugar.

After Dexcom, he cofounded Sabur Technology, which also focuses on blood sugar monitoring, and founded Wonder Spray, which sells a spray purported to soothe rashes and promote clear, healthy skin. Burr holds a doctorate in biochemistry from the University of Wisconsin.

Lysulin’s supplement contains vitamin C, zinc and lysine — all of which are available over the counter, though Lysulin has patented its particular blend. Burd says he came up with the formulation after reading scientific papers that showed that each of these components can lower blood sugar.

One of those papers was authored by a team of Sri Lankan researchers. Burd asked the scientists if they would run a clinical trial testing the product, and they agreed.

Lysulin funded the study, which cost $80,000.

“You can’t find grant money to do studies with supplements,” Burd said. “You’ve got to take money out of your own pocket to fund the study. That’s just the nature of doing business.”

Researchers recruited 110 Sri Lankan adults with higher-than-normal blood sugar levels that often precede a diabetes diagnosis. Half of the participants were randomly selected to take Lysulin, while the rest took a placebo pill every day for six months.

The study’s authors reported that 25 percent of those who took the placebo developed diabetes during the study, compared to only seven percent of those on Lysulin. Those in the Lysulin-taking group also had lower blood sugar and cholesterol levels.

In 2018, Lysulin published another study based in Tijuana reporting that its supplement reduced average blood sugar levels and improved blood pressure in those with type 2 diabetes. The most recent study was published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews, the official journal of the organization DiabetesIndia.

Dr. Luc Teyton, a trained physician and Scripps Research immunologist, sees red flags in the report. He says that typically only seven to 10 percent of prediabetics develop diabetes within a year. So it’s surprising that one in four people in the placebo group developed diabetes within six months.

He also points out that, at the start of the study, people in the placebo group already had higher blood pressure, reported less physical activity and consumed more dietary fat than those in the Lysulin-taking group. Those differences point to issues with how the study was designed, he says, and may account for some of its findings.

“It makes no sense,” Teyton said. “I have a hard time taking any of that very seriously.”

Nor is he impressed by past studies that link Lysulin’s key ingredients to diabetes.

“I don’t know how many times vitamin C and zinc have been recycled in the treatment of pretty much everything.”

Morello is concerned by the trial’s small sample size, a limitation that the study’s own authors note. Without a larger trial run by multiple medical centers, she says, it’s hard to know whether Lysulin works for people from different racial and ethnic groups.

“Reduces the progression of diabetes?” Morello said. “How do you make these big, bold statements when you didn’t even have enough patients?”

You don’t need clinical trial data to sell a supplement. The Food and Drug Administration regulates supplements as food, not drugs. Sellers simply need to include a disclaimer on the packaging: “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Lysulin includes that disclaimer. But each bottle also bears an additional note.

Copyright 2026 San Diego Union-Tribune. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms, machine learning models, text and data mining, or similar use is strictly prohibited without explicit written consent.

Join the Conversation